Functional Genetics, Inc.
Gaithersburg, MD, US· latest recorded location
Functional Genetics, Inc. is named on 11 US grants and 20 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 11
- Published applications
- 20
- Inventors
- 24
- Granted in 2026 so far
- 0
- Most recent grant
- 17 Sep 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 1 | 6 |
| 2010 | 1 | 4 |
| 2011 | 2 | 4 |
| 2012 | 2 | 1 |
| 2013 | 3 | 0 |
By publication year.
Technology areas
Share of 31 documents
- A61PTherapeutic uses of medicines22
- C07KPeptides22
- A61KMedicines and medical preparations18
- C12NMicroorganisms or enzymes7
- G01NInvestigating or analysing materials by determining their chemical or physical properties7
- Y02ATechnologies for adaptation to climate change7
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3
- B01JChemical or physical processes1
- B01LChemical or physical laboratory apparatus for general use1
- C07DHeterocyclic compounds1
Recent patents
- Methods of inhibiting HIV infectivity17 Sep 2013US 8,535,684 B2
- Methods for detecting enveloped virus infections by measuring cell surface TSG1012 Jul 2013US 8,476,009 B2
- Random homozygous gene perturbation to enhance antibody production29 Jan 2013US 8,361,792 B2
- Methods of inhibiting viral infection26 Jun 2012US 8,207,209 B2
- Anti-TSG101 antibodies and their uses for treatment of viral infections22 May 2012US 8,182,985 B2
- Methods of inhibiting viral infection7 Jun 2012US 2012/0142731 A1
- Therapeutic targeting of escort proteins24 Nov 2011US 2011/0287019 A1
- Antibodies for diagnosis and therapeutic treatment of prostate cancer25 Aug 2011US 2011/0206695 A1
- Protease inhibitors and broad-spectrum antiviral23 Jun 2011US 2011/0152343 A1
- Random homozygous gene perturbation to enhance antibody production3 Feb 2011US 2011/0027878 A1
Most cited
By later US patents
- Rapid screening assay methods and devices240US 5,922,617 A1999
- Anti-TSG101 antibodies and their uses for treatment of viral infections5US 7,427,468 B22008
- Methods for detecting enveloped virus infections by measuring cell surface TSG1012US 8,476,009 B22013
- Assay for TSG101 as inhibitors of HIV production1US 7,494,767 B22009
- Random homozygous gene perturbation to enhance antibody production1US 7,745,148 B22010